Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
Japan Hospice HoldingsTSE:7061 -0.76%62 EV-to-EBIT is 13.98 as of Sep. 13, 2026, which is 52% below its 10-year median of 29.19. GuruFocus rates TSE:7061 with a GF Score™ of 62/100 and a GF Value™ of 円1,891.43 (Possible Value Trap). The stock has 7 warning signs investors should review. Among 480 Healthcare Providers & Services companies, Japan Hospice Holdings ranks better than 54.79% on this metric.
The historical rank and industry rank for Japan Hospice Holdings's EV-to-EBIT or its related term are showing as below:
TSE:7061'
s EV-to-EBIT Range Over the Past 10 Years
Min: 13.64 Med: 29.19 Max: 135.34
Current: 13.98
During the past 9 years, the highest EV-to-EBIT of Japan Hospice Holdings was 135.34. The lowest was 13.64. And the median was 29.19.
TSE:7061's EV-to-EBIT is ranked better than 54.79% of 480
companies
in the Healthcare Providers & Services industry
Industry Median: 15.06
vs TSE:7061: 13.98
Japan Hospice Holdings (TSE:7061) EV-to-EBIT Explanation
This is a more accurate valuation of companies' operation because it considers the debt and cash on its balance sheet, and non-operating items such as interest payment, tax, and one-time items are not included in the Operating Income.
Japan Hospice Holdings's Enterprise Value for the quarter that ended in Jun. 2026 was 円15,587 Mil.
Japan Hospice Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,114 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Medical Care Facilities subindustry, Japan Hospice Holdings's EV-to-EBIT, along with its competitors' market caps and EV-to-EBIT data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Japan Hospice Holdings EV-to-EBIT vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, Japan Hospice Holdings's EV-to-EBIT distribution charts can be found below:
* The bar in red indicates where Japan Hospice Holdings's EV-to-EBIT falls into.
Japan Hospice Holdings's current Enterprise Value is 円15,570 Mil.
Japan Hospice Holdings's EBIT for the trailing twelve months (TTM) ended in Jun. 2026 adds up the quarterly data reported by the company within the most recent 12 months, which was 円1,114 Mil.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Japan Hospice Holdings (TSE:7061) has a EV-to-EBIT of 13.98 as of Sep. 13, 2026. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Japan Hospice Holdings and its competitors. This is 52% below median its historical median of 29.19. Over the past decade, Japan Hospice Holdings' EV-to-EBIT has ranged from 13.64 to 135.34. According to the industry distribution chart, Japan Hospice Holdings ranks #217 out of 480 companies in the Healthcare Providers & Services industry, placing it in the top 45.2%.
Is Japan Hospice Holdings' EV-to-EBIT too high?
Japan Hospice Holdings' current EV-to-EBIT of 13.98 is 52% below median its 10-year median of 29.19. Over the past 10 years, this metric has ranged from a low of 13.64 to a high of 135.34. The Healthcare Providers & Services industry median EV-to-EBIT is 15.06. Japan Hospice Holdings' value of 13.98 is 7.2% below this industry median. Based on the distribution chart, Japan Hospice Holdings ranks #217 out of 480 companies in the Healthcare Providers & Services industry, which is above the industry midpoint. Overall, Japan Hospice Holdings has a GF Score™ of 62/100 and is considered Possible Value Trap, reflecting its overall financial health beyond just this single metric.
How does Japan Hospice Holdings' EV-to-EBIT compare to HCA and THC?
According to the Healthcare Providers & Services industry distribution chart, Japan Hospice Holdings ranks #217 out of 480 companies for EV-to-EBIT. This puts Japan Hospice Holdings in the upper half of its industry. The industry median EV-to-EBIT is 15.06. Japan Hospice Holdings' value of 13.98 is 7.2% below this benchmark. Historically, Japan Hospice Holdings' own EV-to-EBIT has ranged from 13.64 to 135.34 over the past decade. While the company's 10-year median is 29.19 vs. the industry median of 15.06, Japan Hospice Holdings has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EV-to-EBIT for a Healthcare Providers & Services company?
The median EV-to-EBIT among Healthcare Providers & Services companies is 15.06, based on 480 companies in the industry. Companies in the top quartile (top 25%) have a EV-to-EBIT significantly above this median, while those in the bottom quartile fall well below. However, EV-to-EBIT should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Japan Hospice Holdings's current EV-to-EBIT of 13.98 is 7.2% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EV-to-EBIT mean?
A high EV-to-EBIT can signal that a stock is expensive relative to its fundamentals. EV to EBIT ratio is the inverse of Joel Greenblatt's earnings yield definition. View historical data on Japan Hospice Holdings and its competitors. For the Healthcare Providers & Services industry, the median EV-to-EBIT is 15.06 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Japan Hospice Holdings's current EV-to-EBIT is 13.98, which is 52% below median its own 10-year median of 29.19. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Japan Hospice Holdings stock overvalued right now?
Based on GuruFocus' analysis, Japan Hospice Holdings (TSE:7061) is currently considered Possible Value Trap. The stock's GF Value™ is 円1,891.43, compared to a current price of 円521.00 — trading 72.5% below its estimated fair value. The current EV-to-EBIT is 13.98, which is 52% below median its 10-year median of 29.19 and 7.2% below the Healthcare Providers & Services industry median of 15.06. Japan Hospice Holdings' overall GF Score™ is 62/100 with 7 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EV-to-EBIT calculated?
EV-to-EBIT is calculated from a company's financial statements. For Japan Hospice Holdings (TSE:7061), the current EV-to-EBIT is 13.98 as of Sep. 13, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Japan Hospice Holdings (TSE:7061) Overvalued in 2026?
Based on GuruFocus' analysis, Japan Hospice Holdings stock appears to be undervalued.
The current stock price of 円521.00 is trading 72.5% below its estimated GF Value™ of 円1,891.43.
GuruFocus considers Japan Hospice Holdings to be Possible Value Trap.
Key valuation signals for TSE:7061:
EV-to-EBIT: 13.98 (52% below median its 10-year median of 29.19)
GF Value™: 円1,891.43 vs. price of 円521.00 (72.5% below fair value)
Industry Position: 7.2% below the Healthcare Providers & Services median (#217 of 480)
No single metric tells the full story. See the TSE:7061 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Japan Hospice Holdings Inc is engaged in providing nursing and visiting nursing care services in Japan. The company's services include Hospice house, Home hospice service, and Planning and design supervision commissioned business.
62GF Score
Get the complete analysis for TSE:7061
EV-to-EBIT is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
TSE:7061 has been successfully added to your 
